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Region-specific contribution of the ventral tegmental area to heroin-induced conditioned
immunomodulation
Lee W. Hutson, Jennifer L. Szczytkowski, Timothy B. Saurer, Christina Lebonville, Rita
A. Fuchs, Donald T. Lysle
Abstract
Dopamine receptor stimulation is critical for heroin-conditioned immunomodulation; however, it
is unclear whether the ventral tegmental area (VTA) contributes to this phenomenon. Hence, rats
received repeated pairings of heroin with placement into a distinct environmental context. At
test, they were re-exposed to the previously heroin-paired environment followed by systemic
lipopolysaccharide treatment to induce an immune response. Bilateral GABA agonist-induced
neural inactivation of the anterior, but not the posterior VTA, prior to context re-exposure
inhibited the ability of the heroin-paired environment to suppress peripheral nitric oxide and
tumor necrosis factor-α expression, suggesting a role for the anterior VTA in heroin-conditioned
immunomodulation.
Keywords
Ventral tegmental area
Heroin
Conditioning
Nitric oxide
TNF-α
1. Introduction

Opioid administration has detrimental health consequences in addition to the possible
development of addictive behaviors and dependence. Clinical studies have revealed
abnormalities in basic immune parameters in heroin users, including a decrease in circulating
lymphocytes, natural killer cell activity, cytokine production, and antibody-dependent cellular
cytotoxicity (Govitrapong et al., 1998, Nair et al., 1986, Olson et al., 2005, Yardeni et al., 2008).
Several immune parameters that are critical for innate immune responses are altered by opioid
use, such as the expression of inducible nitric oxide synthase (iNOS) (Lysle and How, 2000) and
the production of the proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and

interleukin-1β (IL-1β) (Chao et al., 1993, Pacifici et al., 2000). These studies suggest that
chronic opioid administration results in an impaired ability to defend against infectious disease
(Theodorou and Haber, 2005).

Interestingly, opioid-induced immunosuppression has been shown to be mediated by the central
nervous system (Fecho et al., 1996, Lysle et al., 1996, Shavit et al., 1986), and the
immunosuppressive effects of exogenous opioid administration can be conditioned to the context
in which the drug is delivered. Indeed, research from our laboratory has shown that the immune
altering effects of opioids, including those of morphine and heroin, can be conditioned to
environmental stimuli by pairing opioid administration with exposure to a distinct environmental
context. As a result, a morphine-paired context can acquire immune altering effects. For
example, following conditioning sessions during which morphine injections were paired with a
distinct context, rats exhibited significant reductions in mitogenic responsiveness of
lymphocytes, natural killer cell activity, and interleukin-2 production when re-exposed to the
distinct context in a drug free state, demonstrating for the first time morphine-conditioned
immunosuppression (Coussons et al., 1992). These findings are commensurate with other studies
exploring the conditioned effects of opiates on other physiological and behavioral processes. For
example, the administration of morphine has been shown to result in the development of
conditioned hyperthermia (Broadbent and Cunningham, 1996, Schwarz-Stevens and
Cunningham, 1993, Schwarz and Cunningham, 1990). Moreover, exposure to stimuli associated
with heroin use has been shown to induce craving for heroin (Daglish et al., 2001, Sell et al.,
2000, Zijlstra et al., 2009). Furthermore, contextual stimuli associated with drug selfadministration have been shown to reinstate heroin-seeking behavior (Bossert et al., 2004,

Bossert et al., 2012, Fuchs and See, 2002). Thus, the study of conditioning processes has
implications for the health consequences of drug use and drug seeking behavior and addiction.

Early evidence suggested that that dopamine and glutamate are involved in conditioned
immunomodulation (Hsueh et al., 1999, Kuo et al., 2001). Findings from our laboratory
demonstrated that dopamine receptor activity was necessary for the expression of opioidconditioned immune alterations, as administration of a dopamine D1-like receptor antagonist
prior to re-exposure to a morphine-conditioned stimulus prevented the suppression of natural
killer cell activity (Saurer et al., 2008a). Similar immunomodulatory effects have also been
demonstrated with heroin (Fecho and Lysle, 2000, Lysle and Ijames, 2002, Saurer et al., 2008a).

Emerging evidence suggests that a limbic neural circuit mediates the expression of heroininduced conditioned immune alterations, and this circuit likely includes the ventral tegmental
area (VTA). In support of this, either GABA agonist-induced neural inactivation of, or dopamine
D1-like receptor antagonism in, the basolateral amygdala (BLA) blocks heroin-induced
conditioned immunosuppression (Szczytkowski and Lysle, 2008, Szczytkowski and Lysle,
2010). Moreover, unilateral dopamine D1-like receptor antagonism in the BLA coupled with
contralateral NMDA glutamate receptor antagonism in the nucleus accumbens (NAc) shell
significantly attenuates the expression of heroin-conditioned immunosuppression (Szczytkowski
et al., 2011). In contrast, ipsilateral manipulation of the same brain regions fails to disrupt
heroin-conditioned immunomodulation (Szczytkowski et al., 2011). These findings suggest that
dopamine in the BLA, via the stimulation of D1-like receptors, is necessary for obligatory

intrahemispheric interactions between the BLA and the NAc in the control of heroin-conditioned
immune alterations.

The critical source of dopamine involved in heroin-conditioned immunomodulation has not been
investigated even though the VTA is a likely candidate. Opioid administration has been long
believed to result in the disinhibition of dopaminergic projection neurons and the subsequent
release of dopamine at terminal regions via the stimulation of μ opioid receptors on VTA
GABAergic inter- and projection neurons (Johnson and North, 1992a). However, recently a
revised model has been proposed, in which opioids directly inhibit GABAergic projections from
the rostromedial tegmental nucleus to VTA dopamine neurons, thereby suppressing tonic
inhibition and resulting in enhanced phasic dopamine activity (Bourdy and Barrot, 2012).
Similarly, heroin-associated stimuli increase the activity of VTA neurons (Kiyatkin and Rebec,
2001). Recent, investigations have focused on elucidating the function of various subregions of
the VTA, and the findings have suggested that the VTA is a heterogeneous structure with distinct
subregions differentially affecting drug-induced behaviors. For example, μ opioid receptor
antagonism in the anterior, but not posterior, VTA prevents the acquisition of cocaine-induced
conditioned place preference (Soderman and Unterwald, 2008). Furthermore, rats self-administer
the GABAA antagonist, picrotoxin, into the anterior, but not the posterior, VTA (Ikemoto et al.,
1997a). A study utilizing retrograde tracing techniques determined that dopaminergic efferents
from the VTA to BLA originate in the anterior VTA (Ford et al., 2006), whereas a large
proportion of dopaminergic projections from the posterior VTA terminate in the NAc (Ikemoto,
2007). Based on these findings and the importance of dopamine signaling in the BLA in
conditioned immunosuppression (Szczytkowski et al., 2011, Szczytkowski and Lysle, 2008,

Szczytkowski and Lysle, 2010), we hypothesized that the functional integrity of the anterior, but
not posterior, VTA is necessary for the expression of heroin-conditioned immunomodulation.

To test this hypothesis, the present study selectively targeted the anterior or posterior VTA in
order to evaluate the distinct contributions of these subregions to the expression of heroininduced conditioned immunomodulation. Rats underwent a conditioning procedure which
consisted of repeated pairings of heroin administration with placement into a distinct
environment. Following the conditioning regimen, rats received microinfusions of saline vehicle
or a cocktail of the GABAB/GABAA agonists, baclofen/muscimol (B/M), into the anterior or
posterior VTA to temporarily inactivate these VTA subregions. Rats were then re-exposed to the
previously heroin-paired environment in a drug free state. Six hours following re-exposure, rats
received a subcutaneous injection of lipopolysaccharide (LPS) to induce an immune response.
LPS is a component of the outer cell membrane of Gram-negative bacteria, which activates the
innate immune response via the CD14/TLR4/MD-2 complex, resulting in a robust
proinflammatory response (Fujihara et al., 2003). To assess context-induced alterations in
immune status, the effects of these manipulations were examined on the expression of the
proinflammatory mediators, iNOS and TNF-α, in the spleen and/or plasma.
2. Materials and methods
2.1. Animals

Male Lewis rats, weighing 225–250 g, were purchased from Charles River Laboratories
(Raleigh, NC, USA). Upon arrival, animals were housed individually in plastic cages in a colony
room with a reversed light–dark (12-h) cycle maintained through artificial illumination. Animals

were allowed access to food and water ad libitum throughout the experiment except for the time
spent in the conditioning chambers when food and water were not available. All animals were
given a 2-week habituation period before the start of experimental manipulations and were
handled regularly during this time. All procedures described were approved by the IACUC of the
University of North Carolina at Chapel Hill and conformed to National Institutes of Health
(NIH) Guidelines on the Care and Use of Laboratory Animals.
2.2. Drug administration

Heroin (diacetylmorphine) was obtained from NIDA (Bethesda, MD, USA) and dissolved in
0.9% sterile saline. Heroin was administered subcutaneously at a dose of 1 mg/kg. This dose was
selected based on prior experiments in our laboratory showing that it induces conditioning and
alters LPS-induced iNOS and TNF-α mRNA expression in spleen tissue (Lysle and How, 2000,
Lysle and Ijames, 2002, Szczytkowski and Lysle, 2007).
2.3. Surgical procedures

Animals were fully anesthetized with 0.35 mL intramuscular injections of 1:1 (vol:vol) ketamine
hydrochloride (100 mg/mL) mixed with xylazine (20 mg/mL) and placed into the stereotaxic
apparatus. Animals were implanted bilaterally with 26-gauge guide cannulae (Plastics One,
Roanoke, VA, USA). The cannulae were angled at 10° and directed towards the anterior VTA
(AP −5.0, ML ± 2.2, DV −6.1 mm, relative to bregma) or posterior VTA (AP −6.0, ML ± 2.1,
DV −6.3 mm, relative to bregma). Animals were given a 2-week post-surgical recovery period
before the start of conditioning trials.
2.4. Conditioning procedure

All animals received five conditioning sessions in standard conditioning chambers (BRS/LVE,
Laurel, MD, USA). Chambers were fitted with a metal grid floor design and cedar bedding to
create an environment distinct from that of the home cage and to provide both olfactory and
tactile cues for conditioning. Artificial noise machines were used to minimize background noise.
All conditioning took place during the dark phase of the light cycle in a room separate from the
animal colony and the conditioning chambers were kept dark to minimize effects on circadian
rhythms. On each conditioning day, a subcutaneous injection of heroin (1 mg/kg) was
administered immediately prior to placement into the chamber for 60-min. Training sessions
were separated by 48 h.
2.5. Test of heroin-conditioned immunomodulation

Six days following the final conditioning session, animals received bilateral microinfusions of
saline vehicle (0.3 μL per hemisphere) or B/M (0.3/0.03 nmol per 0.3 μL per hemisphere) into
the anterior or posterior VTA. Injectors extended 3 mm beyond the tip of the guide cannula.
Injections were delivered over 1 min, and the injectors were left in place for 1 min after the
injection to allow for proper diffusion of fluid away from the infusion site. Thirty minutes later,
the rats were re-exposed to the previously heroin-paired conditioning chamber or remained in
their home cages (home cage control groups) for 60 min. Heroin was not administered on the test
day in order to isolate the effect of the context on immune responses. After the 60-min time
period, all rats received a subcutaneous injection of LPS (1000 μg/kg) and were immediately
returned into their home cages. LPS, a component of the cell wall of Gram negative bacteria, was
used to induce iNOS and TNF-α production. Prior work from our laboratory has determined the

dose and route of delivery used in the present study to be effective in generating a robust
proinflammatory response (Szczytkowski et al., 2011, Szczytkowski and Lysle, 2007,
Szczytkowski and Lysle, 2008, Szczytkowski and Lysle, 2010) 6-h after LPS administration, all
animals were euthanized. The 6-h time point was selected based on previous research in our
laboratory showing maximal iNOS induction 6 h following LPS administration (Lysle and How,
2000).
2.6. Histology

Samples of spleen and blood were collected for analysis. Spleen samples were either stored in an
Ambion® RNA Later solution or Roche complete protease inhibitor cocktail solution. To
confirm proper cannula placement, Alcian blue dye was infused via the cannula. Brains were
then extracted and post-fixed in a 4% paraformaldehyde solution. Following fixation the brains
were transferred to a 30% sucrose solution for cryoprotection and then frozen at −80 °C until
further analysis. Coronal sections (40 μm) were taken and stained with cresyl violet for
verification of cannula placement. The data of animals with cannula placement outside of the
targeted region were removed from subsequent data analyses.
2.7. Real-time qRT-PCR

To determine iNOS and TNF- α expression, real time RT-PCR was performed on tissue samples
from the spleen. Total RNA was extracted from a section of each of the tissues using TRIReagent (Molecular Research Center, Cincinnati, OH), a modification of the original method
described by Chomczynski and Sacchi (1987). RNA was quantified spectrophotometrically
(GeneQuant II, Pharmacia-Biotech, Piscataway, NJ, USA). Reverse transcription was performed

using Oligo(dT)18 primer and Moloney Murine Leukemia Virus-Reverse transcriptase following
the protocol of the Advantage RT-for-PCR Kit from Clontech (Palo Alto, CA, USA). Specific
products from the PCR reaction were detected with Universal ProbeLibrary Probes (Roche,
Indianapolis, IN). PCR amplifications were performed using standard protocols, the LightCycler
TaqMan Master Real-Time PCR Kit, and the LightCycler II instrument (Roche, Indianapolis,
IN). A master mix containing all reaction components was prepared and then 20 μl of cDNA
with master mix was placed in glass capillary tubes designed for use in the LightCycler II
system. Primers and probes for immune parameters were as follows: (iNOS) 5′TGAGGATTACTTCTTCCAGCTCA-3′ and 5′-TGGGTGTCAGAGTCTTGTGC-3′, using
probe #25; (TNF-α) 5′-GGGCCTCCAGAACTCCAG-3′ and 5′-GAGCCATTTGGGAACTTCT3′, using probe #98. Primers were synthesized by the Nucleic Acids Core Facility (Lineberger
Cancer Center, UNC-Chapel Hill). Copy numbers were generated based on an internal standard
curve. Amplifications were carried out for 45 cycles and curves showing fluorescence at each
cycle were determined by the computer software (Roche). Samples were pre-incubated for 10
min at 95 °C to activate the Fast-Start Taq DNA polymerase. The cycle temperatures were 95
and 60 °C and the cycle times were 10 and 30 s for the denaturing and annealing/extending,
respectively. Fluorescence level was determined at the end of the extending phase for each cycle
of PCR. A final cooling phase was carried out at 40 °C for 30 s. The analysis of the fluorescence
in standards and samples over the course of 45 cycles was used to derive the number of copies of
the target molecule in each sample. Additionally, assessments of housekeeping gene expression,
L13A, were made to verify comparable RNA quality of among samples. L13A primers were 5′CCCTCCACCCTATGACAAGA-3′ and 5′-GGTACTTCCACCCGACCTC-3′, using probe #74.
The data are expressed as copy numbers.

2.8. Nitrite/nitrate assay

The nitrite/nitrate concentration in plasma samples was assessed using the Greiss reagent assay
described previously (Szczytkowski and Lysle, 2007). Briefly, 6 μl of plasma was diluted in 44
μl of dH2O, and the sample was incubated in the dark for 90 min with 10 μl of nitrate reductase
(1.0 U/ml), 20 μl of 0.31 M phosphate buffer (pH 7.5), 10 μl of 0.86 mM NADPH (Sigma), and
10 μl of 0.11 mM flavin adenine dinucleotide in individual wells of a 96-well plate. Next, 200 ml
of Greiss reagent, consisting of a 1:1 (v/v) solution 1% sulfanilamide in 5.0% phosphoric acid
and 0.1% N-(1-napthyl) ethyl-enedamine dihydrochloride in distilled water, was added to the
samples. The color was allowed to develop for 10 min at room temperature, after which, the
absorbance was determined using a spectrophotometer set at 550 nm. All reactions were carried
out in triplicate. The total micromolar concentration of nitrite was determined for each sample
based on a standard curve. Recovery of nitrate is greater than 95% using this assay.
2.9. ELISA

To assess TNF-α protein expression, protein was extracted from homogenized tissue using
freeze/thaw lysis in tris-buffer containing antiproteinases. Protein was quantified
spectrophotometrically (Bio-Tek, μQuant Monochromatic Microplate Spectrophotometer,
Winooski, VT, USA) using Bio-Rad protein dye. Samples were normalized per unit protein
based on spectrophotometric analysis. Invitrogen (Carlsbad, CA) rat TNF-α ELISA test kits were
used to determine the levels of TNF-α protein in each tissue sample. The samples were processed
following the kit manufacturer’s protocol. Sample concentrations were determined based on
plotting absorbance against the concentrations of supplied standards.

2.10. Statistical analysis

Two-way analysis of variance was performed on all data sets. The first factor was test context,
which compared re-exposure to the conditioned environment to home cage groups, and the
second factor was inactivation treatment, comparing VTA inactivation with B/M or saline. Posthoc analyses were performed using Fisher’s Least Significant Difference tests. All analyses were
conducted with alpha set at p < 0.05. Only significant interactions and main effects are reported.
3. Results
3.1. Anterior VTA inactivation

Fig. 1A shows the effect of anterior VTA inactivation on LPS-induced heroin-conditioned iNOS
mRNA expression in spleen tissue following exposure to the heroin-paired context or the home
cage. The ANOVA of iNOS mRNA copy numbers revealed a significant context by treatment
interaction effect [F(1,16) = 14.88, P < 0.005]. Post-hoc analyses revealed that saline-treated rats
exposed to the heroin-paired context exhibited a significant reduction in iNOS mRNA expression
compared to that in the home cage. In contrast, rats that received intra-VTA microinjections of
B/M failed to exhibit differences in iNOS mRNA expression after exposure to the previously
heroin-paired environment or the home cage. There were also no differences across groups in
housekeeping gene expression (data not shown).
Fig. 1B shows the effect of anterior VTA inactivation on LPS-induced plasma nitrate/nitrite
levels. The ANOVA of nitrate/nitrite levels revealed a significant context by treatment
interaction effect [F(1,16) = 5.83, P < 0.05]. Post-hoc analyses revealed that saline-treated rats
exposed to the heroin-paired context exhibited a significant reduction in iNOS mRNA expression

compared to that in the home cage. Rats that received intra-VTA microinjections of B/M failed
to exhibit differences in iNOS mRNA expression after exposure to the two contexts and
compared to the saline-treated home cage control group.

Fig. 2 shows the effect of anterior VTA inactivation on LPS-induced TNF-α mRNA and protein
expression. The ANOVA found a significant context by treatment interaction effect for TNF-α
mRNA expression [F(1,16) = 6.46 P < 0.05] and TNF-α protein levels [F(1,15) = 4.57, P < 0.05].
Post-hoc analyses revealed that saline-treated rats exposed to the heroin-paired context exhibited
a significant reduction in TNF-α mRNA expression and protein levels compared to home cage
animals. By comparison, animals that underwent anterior VTA inactivation prior to context reexposure showed no significant difference in LPS-induced TNF-α mRNA expression or protein
levels compared to anterior VTA saline infused controls. No differences in housekeeping gene
expression were observed across groups (data not shown).
3.2. Posterior VTA inactivation

Fig. 3A shows the effect of posterior VTA inactivation on LPS-induced iNOS mRNA
expression. Analysis revealed a significant context main effect only [F(1,15) = 20.32, P <
0.0001]. Thus, context re-exposure produced a similar decrease in iNOS mRNA expression in
the posterior VTA inactivated and control groups, relative to home cage exposure.
Fig. 3B shows the effect of posterior VTA inactivation on LPS-induced nitrate/nitrite levels in
blood plasma. The ANOVA also revealed a context significant main effect only [F(1,15) = 7.28,
P < 0.05]. Therefore, context re-exposure produced a similar decrease in nitrate/nitrite levels in
the posterior VTA inactivated and control groups, relative to home cage exposure.

Fig. 4A shows the effect of posterior VTA inactivation on LPS-induced TNF-α mRNA
expression. The ANOVA of TNF-α mRNA expression revealed a marginally significant main
effect of context [F(1,14) = 4.22, P = 0.059]. Thus, context re-exposure produced a similar
decrease in n TNF-α mRNA expression in the posterior VTA inactivated and control groups,
relative to home cage exposure.
Fig. 4B shows the effect of posterior VTA inactivation on LPS-induced TNF-α protein levels.
The ANOVA of TNF-α protein levels revealed significant context [F(1,15) = 14.68, P < 0.005]
and drug treatment main [F(1,15) = 10.12, P < 0.01] effects. Thus, the posterior VTA inactivated
group exhibited lower TNF-α protein levels than the saline control group. However, context reexposure produced a similar decrease in n TNF-α mRNA expression in the posterior VTA
inactivated and control groups, relative to home cage exposure.
4. Discussion

In the present study, neural activity in the anterior or posterior VTA was inhibited using GABA
agonists prior to re-exposure to a heroin-paired environmental context in order to determine
whether subregions of the VTA play different roles in the expression of heroin-conditioned
immune alterations. Anterior VTA neuronal inactivation disrupted the immunosuppressive
effects of the heroin-paired context on LPS-induced TNF-α and iNOS expression. This suggests
that the functional integrity of the anterior VTA is necessary for the expression of heroin-induced
conditioned immune suppression of proinflammatory mediators. In marked contrast, posterior
VTA inactivation failed to alter heroin-paired context-induced alterations of proinflammatory
mediators even though it produced a context-independent reduction in TNF-α protein levels.

Overall, this pattern of findings suggests that the anterior VTA, but not the posterior VTA, has a
critical role in heroin-induced conditioned immune alterations. These findings expand our
understanding of the neural circuitry involved in heroin-conditioned immunomodulation by
identifying a source of dopamine that alters the activity of several other brain regions within the
mesolimbic dopamine system, as well as provide insight into the neural mechanisms of drugs of
abuse.

Previous research in our laboratory suggests that dopamine regulates multiple elements of the
neural circuitry underlying conditioned immunomodulation. In support of this, inactivation of the
BLA and blockade of dopamine D1-like receptors within the BLA prevent the suppressive effect
of the heroin-associated context on iNOS induction and on TNF-α and IL-1β expression in
spleen and liver tissue (Szczytkowski and Lysle, 2008, Szczytkowski and Lysle, 2010).
Dopamine D1-like receptor antagonism in the NAc shell blocks the expression of morphineinduced conditioned immune alterations (Saurer et al., 2008b). In a recent functional
disconnection study from our laboratory (Szczytkowski et al., 2011), we provided evidence that
the NAc plays a critical role in heron-conditioned immunomodulation as an element of a larger
VTA-BLA-NAc circuit. In that study, rats received unilateral administration of the D1-like
dopamine antagonist, SCH23390, in the BLA in combination with unilateral administration of an
NMDA or AMPA/kainate antagonist into the ipsilateral or contralateral NAc on test day.
Contralateral manipulation (i.e., disconnection) of the VTA-BLA-NAc circuit inhibited the
heroin-conditioned immunosuppression of iNOS and TNF-α expression in the spleen.
Conversely, the ipsilateral manipulation, which left intrahemispheric information processing
between the BLA and NAc intact in one hemisphere, failed to alter proinflammatory responses.

Given that the VTA is one of the primary sources of dopamine to the BLA (Rosenkranz and
Grace, 1999), these findings suggest that serial information processing via a VTA-BLA-NAc
circuit is necessary for the expression of heroin-conditioned immunomodulation. However, the
direct role of the VTA and the subregions of the VTA in conditioned heroin effects had not been
investigated prior to this study.

There are studies consistent with the present findings demonstrating functional differences
between subregions of the VTA, as microinfusions of the GABAA agonist muscimol into the
anterior, but not posterior VTA, significantly reduced cocaine self-administration (Lee et al.,
2007). Furthermore, rats will self-administer the GABAA receptor antagonist, picrotoxin, into
the anterior, but not the posterior, VTA (Ikemoto et al., 1997b). This effect may be mediated by
the disinhibition of dopaminergic neurons in the anterior VTA and subsequent dopamine release
in the NAc since picrotoxin administration into the anterior VTA increases dopamine overflow
in the NAc (Ikemoto et al., 1997a). Functional differences between anterior and posterior VTA
subregions reflect differences in neurochemistry and connectivity between these VTA subregions
(Johnson and North, 1992b, Swanson, 1982). For example, the anterior and posterior VTA
contain different proportions of dopaminergic and glutamatergic neurons and GABAergic
interneurons, with a higher proportion of GABAergic interneurons and dopaminergic neurons
located in the anterior VTA and posterior VTA, respectively (Olson et al., 2005, Yamaguchi et
al., 2007). Interestingly, VTA efferents to the BLA are localized in the anterior VTA, which was
verified using retrograde tracing techniques (Ford et al., 2006, Ikemoto, 2007). Conversely,
dopamine neurons from the posterior VTA project to NAc core and medial shell, with a
significant amount of overlap in projections between the anterior and posterior VTA.

Given the previously discussed importance of dopamine in the BLA in heroin-conditioned
immunosuppression, we hypothesized that the anterior, but not posterior, VTA would be
important in the expression of heroin-conditioned immunomodulation. The results of the present
study support this hypothesis. Our findings also suggest that projections from the posterior VTA,
which include projections to the NAc shell and core, are not critical for the expression of the
observed heroin-conditioned suppression of proinflammatory mediators. On the other hand,
dopaminergic signaling to the NAc originating from the anterior VTA may play a role in heroinconditioned immunosuppression. Importantly, interactions between the VTA, NAc, and BLA
appear to be complex, as dopamine release in the NAc is proposed to be regulated by BLA
glutamatergic efferents (Jones et al., 2010). Consistent with this, temporary neural inactivation of
the BLA results in decreased discriminative stimulus-induced evoked NAc dopamine release. In
addition, BLA inactivation has no effect on NAc dopamine release following VTA stimulation,
indicating that the BLA does not modulate dopamine release indirectly through the VTA
(Howland et al., 2002). Taken together, these previous findings suggest that dopaminergic
signaling from the anterior VTA may result in dopamine release at the terminal level in the NAc.

The present studies do not address the inputs responsible for the activation of the VTA. In other
studies, we have demonstrated that inactivation of the dorsal hippocampus prevents heroinconditioned immunosuppression of LPS-induced nitric oxide production (Szczytkowski et al.,
2013). Furthermore, a recent study demonstrated that a bi-synaptic functional circuit conveys
information from the CA3 region of the dorsal hippocampus to the anterior VTA via the lateral
septum (LS). As a result, GABA agonist-induced inactivation of the LS attenuates excitatory and

inhibitory neuronal firing in the VTA following CA3 stimulation. In addition, inactivation of the
CA3, as well as the LS, impairs drug context-induced reinstatement of cocaine-seeking behavior
(Luo et al., 2011). These findings suggest that activation of CA3 glutamatergic pyramidal
neurons results in the disinhibition of VTA dopamine neurons via this circuit, thus contributing
to the expression of context-reward associations. It is possible that similar mechanisms play a
role in heroin-conditioned immunomodulation.

In conclusion, the present study demonstrates that GABA agonist-induced inactivation of the
anterior, but not posterior, VTA blocks heroin-conditioned immunosuppression of iNOS
induction and the expression of TNF-α in spleen tissue. Taken together with previous findings,
these results enhance our understanding of the neural circuit involved in the conditioned effects
of heroin on immune function. Furthermore, these findings elucidate the mechanisms responsible
for the increased susceptibility to infections associated with drug use, as well as contribute to the
understanding of drug conditioning neural circuitry.
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